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A B S T R A C T
Leishmania donovani is the responsible agent for visceral leishmaniasis (VL) in the Indian subcontinent (ISC). The
disease is lethal without treatment and causes 0.2 to 0.4 million cases each year. Recently, reports of VL in
Nepalese hilly districts have increased as well as VL cases caused by L. donovani from the ISC1 genetic group, a
new and emerging genotype. In this study, we perform for the ﬁrst time an integrated, untargeted genomics and
metabolomics approach to characterize ISC1, in comparison with the Core Group (CG), main population that
drove the most recent outbreak of VL in the ISC. We show that the ISC1 population is very diﬀerent from the CG,
both at genome and metabolome levels. The genomic diﬀerences include SNPs, CNV and small indels in genes
coding for known virulence factors, immunogens and surface proteins. Both genomic and metabolic approaches
highlighted dissimilarities related to membrane lipids, the nucleotide salvage pathway and the urea cycle in ISC1
versus CG. Many of these pathways and molecules are important for the interaction with the host/extracellular
environment. Altogether, our data predict major functional diﬀerences in ISC1 versus CG parasites, including
virulence. Therefore, particular attention is required to monitor the fate of this emerging ISC1 population in the
ISC, especially in a post-VL elimination context.
1. Introduction
Visceral Leishmaniasis (VL) or kala-azar is a neglected tropical dis-
ease globally responsible for 0.2 to 0.4 million cases each year (Alvar
et al., 2012). The disease is lethal without treatment and caused by
protozoan parasites of the Leishmania donovani complex. Transmission
occurs by sand ﬂies of the Phlebotomus genus. In the Indian subcontinent
(ISC), VL is of major concern for public health with>200 million people
at risk (Ostyn et al., 2011). The recent whole-genome sequencing and
phylogenomic analysis of 204 Leishmania strains from the ISC (India,
Nepal and Bangladesh), revealed that the most recent VL epidemic in this
region were essentially driven by one large L. donovani population that
emerged around 1850 and spread across the lowlands in the Ganges
plain. Given its recent origin, this population is genetically very homo-
geneous (Imamura et al., 2016) and was called the Core Group (CG).
Before 2000, sporadic VL cases were reported in the hilly regions of
Nepal (1 km above sea level) and were considered the result of travel,
rather than a local transmission cycle. However, more recently reports
of VL have been increasing in these Nepalese highlands and transmis-
sion has been shown to occur locally (Ostyn et al., 2015). Interestingly,
some isolates derived from VL patients in this region belong to a ge-
netically distinct population of L. donovani (called ISC1), which di-
verged much earlier than 1850 (Imamura et al., 2016). Rai et al. (2017)
investigated the geographic spread of diﬀerent L. donovani genotypes
over a period of 12 years (2002–2014) in Nepal and showed that the
frequency of ISC1 was increasing in the country and that this emerging
genotype was also present in the lowlands. Our earlier study showed
that out of all sampled ISC1 isolates, 75% of them came from patients
relapsing to miltefosine treatment, vs 50% for the CG strains (Imamura
et al., 2016). We have also demonstrated experimentally that ISC1
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parasites need more time and molecular changes to develop antimonial
(Sb) resistance in vitro than CG strains, which led to the hypothesis of
Sb-resistance pre-adaptation of the CG, but not of ICS1 (Dumetz et al.,
2018).
Since 2005, the kala-azar elimination programme (KAEP) has been
running in India, Nepal and Bangladesh, based on vector control and
detection/treatment of VL cases. In such a programme, it is essential to
track parasites and in particular to characterize emerging populations
like ISC1 or the parasites recently reported in Sri Lanka (Zhang et al.,
2014), as these could react diﬀerently to control tools like diagnostics,
drugs or vaccines. In this context, we report here the results of a deep
molecular comparison between ISC1 and CG parasites. In the present
study, we focused on parallel untargeted genomics and metabolomics,
hereby undertaking the ﬁrst Leishmania diversity study integrating
these two ‘omics layers.
2. Methods
2.1. Parasites
Nine L. donovani strains cloned from seven Nepalese and two Indian
clinical isolates were analyzed in this study (Supplementary Table
S1.1). Among these are ﬁve ISC1 strains (BPK026/0, BPK604/0,
BPK612/0, BPK519/12, BPK406/6) and two Nepalese (BPK275/0,
BPK282/0) as well as two Indian (BHU568/0, BHU573/0) strains from
the CG. Promastigotes of all strains were grown in modiﬁed Eagle's
medium (Invitrogen) supplemented with 20% (v/v) heat inactivated
fetal calf serum (PAA Laboratories GmbH, Linz, Austria) pH 7.5 at
26 °C. At each passage, all parasite lines were inoculated to a starting
concentration of 5∙105 parasites/mL and growth was followed for two
passages enabling synchronized sampling of the diﬀerent cultures and
minimizing the eﬀect of diﬀerences in growth rate between strains. For
each strain, four growth replicates were cultured for metabolomics
analysis and one for genome sequencing. Metabolites were extracted in
stationary growth phase according to t'Kindt et al. (2010) and DNA with
the QIAamp DNA Blood Mini Kit (Qiagen).
2.2. Genomics
2.2.1. Library preparation and sequencing
Library preparation and sequencing for BPK026, BPK604, BPK612,
BPK512, BPK406 was performed at the Wellcome Trust Sanger Institute
(Hinxton, United Kingdom). Genomic DNA was sheared into 400–600-
base pair fragments by focused ultrasonication (Covaris Adaptive
Focused Acoustics technology (AFA Inc., Woburn, USA)) and standard
Illumina libraries were prepared. 125 base pair paired end reads were
generated on the HiSeq 2000 v4 according to the manufacturer's
standard sequencing protocol (Bronner et al., 2014). Libraries of
BPK275, BPK282, BHU568 and BHU573 were prepared and sequenced
at the Beijing Genomics Institute (BGI). Brieﬂy, mechanical shearing
with the Covaris (Illumina) was used to create 250-350 bp fragments,
after which the fragment ends were repaired and 3′ A-tailed. Adapters
were subsequently ligated and the target fragments were recovered
from a 2% agarose gel after electrophoresis. Finally, the libraries were
PCR ampliﬁed and 2×151 BP sequenced on an Hiseq 4000. All
sequencing data of this study was submitted to the Sequence Read
Archive (SRA) under accession number SRP125482. Individual acces-
sion numbers for each sample are available in Supplementary Table S2.
2.2.2. Data analysis
Genomic analysis was performed as described in Dumetz et al.
(2017). Brieﬂy, reads were mapped to the L. donovani LdBPKv2 re-
ference genome (9) using Smalt v7.4 (www.sanger.ac.uk/resources/
software/smalt/) and the options exhaustive searching (−x), read
identity threshold of 80% (−y 0.8) and random mapping of multiple
hits reads. Duplicate reads were marked with Picard v1.85 and SNPs
and small indels were called using the GATK haplotypecaller v3.4
(McKenna et al., 2010). Low quality SNPs were marked using GATK
Variant Filtration with paramers: “QD<2.0 || MQ<40 || FS>60.0 ||
ReadPosRankSum< -8.0” and removed from further analysis. The
same tool was used for ﬁltering indels, but with parameters “QD<2.0
|| FS>200.0 || ReadPosRankSum< -20.0 || SOR>200”. Variants
were annotated with SnpEﬀ v4.1 (Cingolani et al., 2012). SNPs and
small indels were considered signiﬁcantly diﬀerent between CG and
ISC1, when the allele shift diﬀerence was at least 0.25 (Tihon et al.,
2017) and Mann–Whitney U test p-value<0.05. Allele shifts larger
than 0.80 were considered homozygous variants (Tihon et al., 2017).
Local copy number variation and chromosomal somy were determined
according to Downing et al. (2011). For somy estimation, initially, the
median read depth of each chromosome was calculated (di). All posi-
tions with a read depth>1 standard deviation away from this initial
median were then removed and di was recalculated. This approach
removed depth outliers by assembly errors, local CNVs or spurious high
coverage regions impacting the ﬁnal median. Subsequently, the median
depth of the 36 chromosomes dm was calculated and the somy (s-value)
of each chromosome was obtained with the following formula s=2*di/
dm. Haploid gene copy number was deﬁned to be the median depth of a
gene divided by the median depth of the chromosome on which it is
located. We used two criteria to evaluate whether a gene or chromo-
some copy number diﬀerence between the CG and ISC1 strains was
biologically meaningful and statistically signiﬁcant. The ﬁrst require-
ment was that the absolute diﬀerence in gene/chromosome copy
number between CG and ISC1 should be at least 0.5 (Dumetz et al.,
2017). Secondly, the FDR adjusted p-value (Student t-test + Benjamini
Hochberg correction) had to be lower than 0.05.
2.3. Metabolomics
2.3.1. Liquid chromatography and mass spectrometry
Samples were analyzed with LC-MS using an Orbitrap Exactive mass
spectrometer (Thermo Fisher) coupled to a 2.1 mm ZIC-HILIC column at
Glasgow Polyomics (University of Glasgow, Scotland) (Sequant), ex-
actly as previously described (Berg et al., 2015). Both negative and
positive ion modes were run in parallel with rapid polarity switching.
Several quality control samples were run at the start, middle and end of
the LC-MS run to aid accurate metabolite identiﬁcation and verify LC-
MS stability (Berg et al., 2013a). These included: 1) Authentic standard
mixes containing in total 217 metabolites (50–400 Da) representing a
wide array of metabolic classes and pathways. 2) An amino acid stan-
dard mix (Sigma Product No. A9906). 3) Serial dilutions (Undiluted, 1/
2, 1/4, 1/8 and 1/16) of a pooled sample of all extracts to ﬁlter out
spurious signals that do not follow the dilution trend (Jankevics et al.,
2012).
2.3.2. Data preprocessing
Data analysis was performed using the XCMS 1.42.0 (Smith et al.,
2006) and mzMatch 1.0.1 (Scheltema et al., 2011) packages in R as
described previously (Berg et al., 2013b). In summary, mzXML ﬁles
were ﬁrst subjected to retention time alignment using ObiWarp (Prince
and Marcotte, 2006) and peak detection with the centWave algorithm
(Tautenhahn et al., 2008). Corresponding peaks from the 4 biological
replicates were subsequently combined and ﬁltered on a maximum
allowed reproducibility standard deviation (RSD) of 0.5. Peaksets from
all samples were then combined and ﬁltered further, requiring for each
peak a minimal scaled CoDA-DW quality value of 0.8 (mzMatch
noiseﬁlter), detection in at least 3 out of 4 replicates and a minimal
peak intensity of 3000. The gapﬁller tool was used to fetch peaks from
the mzXML ﬁles that were missing in one or more samples and deri-
vative peaks were annotated (Scheltema et al., 2009). The peaks were
then putatively identiﬁed allowing 2 ppm of mass deviation using se-
quentially the LeishCyc database (Doyle et al., 2009), LipidMAPS (Fahy
et al., 2007), KEGG (Kanehisa et al., 2017), the peptide database
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included in mzMatch and the Human Metabolome Database (Wishart
et al., 2007). Each time, only unmatched peaks were aligned against the
next database, reducing the number of potential identiﬁcations to the
most likely candidates (Scalbert et al., 2009). Peaks of which the in-
tensity did not follow the dilution pattern in the pooled sample dilution
series (Pearson correlation>0.8 or p-value> .05) were removed from
the analysis with the mzMatch Dilution Trend Filter tool (Jankevics
et al., 2012). The remaining peaks were normalized for total ion count
and visually veriﬁed before exporting them to a csv ﬁle containing all
peak heights, retention times and relevant database annotations. The
full analysis script and detailed parameter settings are available in
Supplementary Table S5. The csv ﬁles from the positive and negative
ionization mode were then merged. When metabolites were identiﬁed
in both modes, only the results from the most intense peak were kept.
2.3.3. Data exploration and statistics
For the initial data exploration, principal component analysis (PCA)
was performed in R directly on the metabolite intensity values of each
sample. Subsequently, the relative expression between the CG and ISC1
strains was calculated for each individual metabolite (Jara et al., 2017).
Brieﬂy, ﬁrst the average metabolite intensity was calculated per strain.
Then, the obtained values were again averaged over the ISC1 strains
and over the CG strains. Finally, these strain averages were converted
into base-2 logarithm ratios between the two populations, henceforth
called the ‘Log2 Fold Change’ (Log2FC). A two-sample t-test assuming
unequal variance was applied to the strain averages to calculate whe-
ther or not this Log2FC was signiﬁcant (p < 0.05).
To investigate the overall correlation between genome and meta-
bolome, we calculated three types of pairwise distances between all
strains: 1) The SNP distance (S-distance) was deﬁned as the total
number of SNP allele changes between a strain pair. In this calculation,
a heterozygous SNP was counted as a distance of 1, while a homozygous
SNP was counted as a distance of 2. 2) The gene dosage distance (GD-
distance) was determined by taking the Euclidean distance between two
strains based on all absolute gene copy diﬀerences; as such, it combined
the eﬀect of CNV and aneuploidy. 3) The metabolic distance (M-dis-
tance) was deﬁned as the Euclidean distance based on all metabolite
intensities, however, since these intensities have a large, metabolite-
speciﬁc dynamic range, they were ﬁrst transformed into Z-scores.
Analysis of the correlation between the respective distances was per-
formed with a non-parametric Mantel test (Mantel, 1967) with 999
permutations, using the QIIME2 package in Python. Contrary to the
classical correlation test, the Mantel test deals with the problem that
distances in a distance matrix are not independent from one other. R2
values were determined by linear regression analysis with the lm
function in R.
3. Results
3.1. Genome sequence diversity
Promastigotes of ﬁve ISC1 (BPK026/0, BPK604/0, BPK612/0,
BPK519/12, BPK406/6) and four CG strains (BPK275/0, BPK282/0,
BHU568/0, BHU573/0) were sequenced with an average read depth of
at least 38.5× and 97.1% of the genome was covered at least 20×.
Detailed mapping to BPK282v2 (Dumetz et al., 2017) and coverage
statistics can be found in Supplementary Table S2. Using new SNP data
of our strains and published ones of East African L. donovani LV9 and Sri
Lankan L. donovani SRI-CLB, we performed a phylogenomic analysis
(Fig. 1). In correspondence with Imamura et al. (2016) (Imamura et al.,
2016), this showed that (i) ISC1 parasites cluster at a larger distance
from CG than the Sri Lanka strain SRI-CLB and (ii) in an intermediate
position with respect to East African L. donovani LV9.
In total, we detected 53,101 SNPs between the CG and ISC1 clusters
(allele shift> 0.25 & pval < 0.05) of which 51,668 were homozygous
(allele shift> 0.8) and of which 19,776 were located in protein coding
regions (Supplementary Table S3). 10,550 of these SNPs caused non-
synonymous codon changes and 24 were ﬂagged by SnpEﬀ for having a
probable high impact on the ﬁnal protein: ﬁfteen premature stop co-
dons were gained, seven stop codons were lost, and two start codons
were gained in ISC1 strains compared to CG ones (Supplementary Table
S1.2). Fourteen of these high impact variants concerned hypothetical
proteins of which the function and impact is unclear. However, of the
remaining ten genes (with homozygous SNPs), three play key roles in
Leishmania virulence (autophagy protein Atg8, trypanothione synthe-
tase and amastin-like surfaceprotein) and two are involved in phos-
phatidylinositol metabolism (CDP-diacylglycerol-inositol 3-phospha-
tidyl transferase and phosphatidylinositol 3- and 4-kinase). While a
high impact is predicted by SnpEﬀ, these genes could certainly still be
functional, as for many of them (including trypanothione synthase,
autophagy protein Atg8 and the amastin-like surface protein) the SNP
was found towards the end of the gene.
Also at the indel level major diﬀerences were observed between
ISC1 and CG with a total of 6435 heterozygous and 5780 homozygous
indels (allele shift> 0.25 and > 0.80 respectively, p-value < 0.05,
Supplementary Table S4). 442 of these indels were located in coding
Fig. 1. Neighbour joining tree based on whole genome SNP loci. Bootstrap support was calculated on 1000 bootstrap replicates. LdonLV9=East African L. donovani
LV9, SRI_CLB=Sri Lankan L. donovani SRI_CLB.
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regions and 83 concerned frameshift mutations, which are often highly
disruptive. A large proportion (58%) of the frameshift indels were lo-
cated in hypothetical proteins, while the 33 functionally annotated
indels (Supplementary Table S1.3) concerned several important biolo-
gical functions, including, but not limited to, transmembrane transport
(Imamura et al., 2016), translation (Ostyn et al., 2011), nucleic acid
binding (Imamura et al., 2016) and nucleotide salvage (Ostyn et al.,
2015). 21 of these annotated indels were homozygous mutations. Re-
markably, two genes encoding for (i) an AAAfamily ATPAse and (ii) a
dihydrouridine synthase domain protein respectively each had two in-
dels. In addition, phosphatidylinositol metabolism was highlighted in
both SNP and INDEL analysis: Phosphatidylinositol-speciﬁc phospholi-
pase C,X/Y/C2 domain containing protein (indel), CDP-diacylglycerol-
inositol 3-phosphatidyl transferase (SNP) and phosphatidylinositol 3-
and 4-kinase (SNP).
3.2. Genome structure diversity
The genome structure was ﬁrst investigated at chromosome level
(Fig. 2). Chromosomal somy estimates do not always correspond to
integer values as these represent the average of a population of cells
that do not necessarily show identical karyotypes (mosaicism). Many
somy diﬀerences were found between chromosomes of diﬀerent strains,
but only two of these were consistent between ISC1 and CG populations
(p-value < 0.05 & |somy diﬀerence| > 0.5). The ISC1 strains had 0.8
copies less of chromosome 8 and 0.7 copies less of chromosome 23.
Secondly, we analyzed local gene copy number variations (CNVs)
between ISC1 and CG isolates. These diﬀerences are the result of gene
ampliﬁcation or deletion events since the most recent common ancestor
of ISC1 and CG. For every gene and sample, copy numbers per haploid
genome are available in Supplementary Table S4. By expressing copy
number diﬀerences per haploid genome, we can describe these changes
independently of the aneuploidy phenomenon. As Leishmania is diploid
for most chromosomes, we used 0.5 copies/haploid genome as a cut-oﬀ,
which corresponds with a single copy for diploid chromosomes. In total
we found 62 loci containing genes with CNVs: for 29 of these loci, genes
were more abundant in ISC1, while for the 33 remaining loci, genes
were more abundant in CG. 29 loci concerned single gene duplications
or deletions (Supplementary Table S1.4). The remaining 33 loci con-
tained multiple genes showing CNVs: (i) 22 contained tandem arrays of
the same gene family, expanding or contracting (Supplementary Table
S1.5); (ii) 11 loci contained sets of genes of a diﬀerent family, all am-
pliﬁed/deleted together (Supplementary Table S1.6).
Duplication/deletions of single copy genes concerned a wide array
of biological functions (Supplementary Table S1.4). Noteworthy, 43%
of the genes with known functions were coding for surface proteins,
virulence factors or immunogens, including GP63, amastins, 60S acidic
ribosomal protein P2 and surface antigen 2. With respect to tandem
arrays of the same gene family (Supplementary Table S1.5), a large
proportion (37%) of the genes with known functions were also coding
for surface proteins, virulence factors or immunogens. More speciﬁ-
cally, we found CNVs of genes coding for amastins, proteophophogly-
cans, HSP70, HSP83, GP63, p1/s1 nucleases, lorien proteins, cysteine
peptidase B and surface antigen 2 proteins. Interestingly, some of these
CNVs were linked to the observations at sequence diversity level.
Indeed, frameshift indels were found in both LdBPK_300020700 coding
for a p1/s1 nuclease, and in LdBPK_120014400 coding for a surface
antigen protein 2. For both genes the adjacent loci contained genes of
the same gene family involved in a CNV. Other families that were
targeted by both sequence and structure variants were amastins and
autophagy protein Atg8. Finally, ampliﬁcations concerning groups of
genes with diﬀerent functions (Supplementary Table S1.6) are ex-
tensively reported to occur as circular episomes (Grondin et al., 1993;
Mukherjee et al., 2007; Chiquero et al., 1994), but also as intra-chro-
mosomal amplicons (Imamura et al., 2016; Olmo et al., 1995). For in-
stance, the H- and M-loci are ampliﬁed in CG strains but have only a
single copy per haploid genome in ISC1. Noteworthy, the H-locus
contains among others the gene encoding for arginine-succinate syn-
thase (ASS, see metabolomics section). Reciprocally, the R-locus (Ubeda
et al., 2014) has a single copy per haploid genome in CG strains, but has
2.15 copies per haploid genome in ISC1 strains. Both the H- and R-
locus have been associated with drug resistance (Grondin et al., 1993;
Kundig et al., 1999). Five of the other ampliﬁed gene groups are as-
sociated with virulence, including proteophosphoglycan, amastins,
surface antigen protein 2 and acid phosphatases. While all three de-
scribed types of CNVs concerned a large proportion of genes coding for
surface proteins, virulence factors and immunogens there was no clear
directionality to these CNVs since we observed both deletions (60%)
and duplications (40%) in ISC1 versus CG.
3.3. Metabolomics
In total, 290 metabolites were identiﬁed with a mass accuracy<
2 ppm, covering a broad diversity of metabolic pathways and re-
presenting the following classes (in order of quantitative representa-
tion): glycerophospholipids (GPLs), amino acids and derivatives, fatty
acyls and carbohydrates, nucleobases and nucleosides, sphingolipids,
steroids and derivatives (Supplementary Table S5 Supplementary Table
S1.4). As a ﬁrst data exploration of the variation in our dataset, we
performed Principal Component Analysis (PCA, Fig. 3). The ﬁrst prin-
cipal component explained 34% of the total variation in our metabo-
lomics experiment and clearly separated the CG (BPK275, BHU573,
Fig. 2. Somy levels in ISC1 and Core Group strains (CG). ISC1 strains are depicted in shades of red and yellow, while CG strains in shades of blue. (For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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BHU568 and BPK282) from ISC1 strains (BPK026, BPK406, BPK519,
BPK604, BPK612). The second principal component explained 23% of
the variation, which separated CG strains in 3 groups: BPK275 (Nepal,
SSG-resistant), BHU573-BHU568 (India, SSG-resistant) and BPK282
(Nepal, SSG-sensitive).
33 metabolites were more abundant in ISC1 strains (Log2FC > 1, p-
value < 0.05), while 12 were more abundant in CG strains
(Log2FC > 1, p-value < 0.05). Interestingly, 19 of these metabolites
were glycerophospholipids (GPLs), providing evidence for major dif-
ferences in lipid metabolism between CG and ISC1 (Fig. 4). In addition,
ISC1 parasites contained higher metabolite levels of phosphor-
ylethanolamine, glycerylphosphorylethanolamine, and glyceropho-
sphoinositol pointing further towards lipid changes between both
groups. Secondly, changes were observed in the urea cycle in ISC1 vs
CG. ISC1 had a 2.1 fold higher amounts of citrulline and 3.6 fold lower
amounts of argininosuccinate. The reaction that involves these meta-
bolites, namely citrulline + aspartate + ATP - > argininosuccinate +
AMP+PPi, is catalyzed by argininosuccinate synthase (ASS). These
metabolite diﬀerences therefore indicate a lower ASS activity in ISC1,
which is in correspondence with the lower copy number of the re-
spective gene in ISC1 (as described in the genome structure diversity
section). Interestingly, the metabolite levels also indicate a diﬀerence
within the nucleotide salvage pathway between both groups, as we
found increased levels of guanine, uracil, thymine, AMP in ISC1 vs CG.
Finally, concentrations of basic amino acids lysine (up) and histidine
(down) were altered in ISC1 vs CG.
We have previously shown that signiﬁcant metabolic variation is
present between SSG-resistant strains (BPK275, BHU573 and BHU568:
CG-R) and SSG sensitive strains (BPK282: CG-S) (Berg et al., 2013b).
Considering these metabolic diﬀerences, we also made individual
comparisons of ISC1 vs CG-R, ISC1 vs CG-S and CG-S vs CG-R. As ex-
pected, this conﬁrmed substantial diﬀerences in the metabolome be-
tween CG-S and CG-R, with 52 metabolites showing a signiﬁcant
(Log2FC > 1, p-value < 0.05) diﬀerence in concentration in only one
of both groups. Consequently, when comparing CG-R and CG-S to ISC1
individually, we found many metabolites only diﬀerential in one of
both comparisons (62 and 51 for CG-R and CG-S respectively), that
were not observed in the original ISC1 vs CG in comparison. However,
when looking in detail to the functions of these newly identiﬁed dif-
ferential metabolites, these related towards the same functional classes
of metabolites as those found when comparing ISC1 to all CG strains
(Supplementary Table S1.7). This shows that although signiﬁcant
metabolome variation within the CG is present, there are clear and
consistent diﬀerences with ISC1 on the level of GPLs, salvage pathway
and urea cycle.
Finally, we compared the metabolomic and genomic polymorphism
to quantify the relationship between both data sets and assess if/how
metabolomic variation could be explained by genomic variation.
Therefore, we computed distances between each pair of isolates, based
on M-distance, S-distance and GD-distance, as explained in the Methods
section. Unfortunately, for the S-distance the intra group variance was
far smaller than the inter group variance, which biases the results.
Therefore we did not analyse S-distance any further. However, this
problem was absent for GD-distance and a Mantel test established a
signiﬁcant positive correlation between M-distance and GD-distance (p-
value= 0.005, Spearman rho=0.64). This means that GD-distance
explains a signiﬁcant proportion of the metabolic distance, but the low
spearman rho indicates that much other variation is present as well.
4. Discussion
In this work we have performed a genomic and metabolic proﬁling
study of strains representing ISC1, a new Leishmania donovani popula-
tion that is currently emerging in Nepal. We have demonstrated that
these parasites are genomically and metabolically very distinct from the
main population (CG) of L. donovani, which was the driver of the most
recent VL epidemic in the Indian subcontinent (Imamura et al., 2016).
From a genomic point of view, the diﬀerences between ISC1 and CG
strongly contrast with the homogeneity of the latter group and ex-
plained by its young evolutionary history (Imamura et al., 2016). First,
we report a large number of SNPs and indels, many of them with a
strong impact (stop codons gained/lost and frameshifts) on several
important biological functions. Secondly, we also encountered diﬀer-
ences in the karyotypes and more particularly two chromosomes
(chromosome 8 and chromosome 23) that showed a lower somy in
ISC1. Somy variation is an adaptive strategy well known in Leishmania,
for instance in response to experimental drug resistance selection
(Prieto Barja et al., 2017), but its interpretation in clinical isolates
needs to be done very carefully. Indeed, we showed that aneuploidy is
strongly dependent on the environment and more abundant in pro-
mastigotes in vitro than in amastigotes within the vertebrate host
(Dumetz et al., 2017). Strictly speaking, we can thus only conclude that
cultivated promastigotes of ISC1 show signiﬁcant karyotypic diﬀer-
ences to those of CG. Further extrapolation of these karyotype diﬀer-
ences to the situation in vivo should be tested by direct sequencing of
clinical samples or in experimental animal infections. A third major
class of genomic changes here observed concerned local copy number
variations (CNVs). In contrast to aneuploidy, these were shown not to
be aﬀected during the life cycle of the parasite (Dumetz et al., 2017),
and CNVs have been shown to be excellent markers for studies on
Leishmania evolution (Dujardin, 2009), both in experimental (for in-
stance, ampliﬁcation of speciﬁc loci during drug resistance selection
(Ubeda et al., 2014; Leprohon et al., 2009)) or in natural settings (for
instance, decrease in copy number of gp63, mini-exon and rDNA genes
in Leishmania peruviana (Victoir et al., 2009; Kebede et al., 1999; Inga
et al., 1998)). In the absence of gene expression regulation at initiation
(Günzl, 2012), ampliﬁcation/deletion of speciﬁc genes is a genomic
solution to modulate the level of transcripts and corresponding pro-
ducts. As such, these CNVs may have an important functional sig-
niﬁcance. In this context, it is striking to observe that many of the CNVs
concerned genes that code for surface proteins, virulence factors or
immunogens: most notably, lower copy numbers of amastins, surface
antigens and GP63 genes were encountered in ISC1. Interestingly, many
Leishmania virulence genes were the target of highly impactful non-
synonymous SNPs (removed/introduced stop codons), such as autop-
hagy protein Atg8, trypanothione synthetase and amastin-like surface
proteins. Although it is impossible to predict now the exact con-
sequences of these SNPs, they are likely to have a high impact at the
Fig. 3. Principal component analysis of the metabolic proﬁles of the 5
Leishmania donovani ISC1 isolates and 4 CG strains in this study. This analysis
was based on the quantitative measurements of all 290 putatively identiﬁed
metabolites. In this PCA plot, average values are shown for each strain based on
four biological replicates. For each principal component, the proportion of
variation of the total dataset it explains is mentioned.
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protein level by extending/shortening the protein. Altogether, genomic
diﬀerences between ISC1 and CG suggest a potential for diﬀerences in
virulence, which should be explored by further work. A ﬁrst experi-
mental veriﬁcation of this hypothesis was made the context of antimony
susceptibility showing CG isolates were pre-adapted to antimony while
ISC1 ones were not. This particular feature could be linked to the
presence of the H-locus ampliﬁcation in the CG (Dumetz et al., 2018).
The metabolome being the molecular expression of the parasite's
phenotype, its study is extremely relevant to detect important func-
tional diﬀerences between organisms. Metabolic diﬀerences between
ISC1 and CG were found in several functional groups and pathways.
First, the most notable changes were found in the lipid metabolism,
with 19 GPLs (predominantly GPCs), showing signiﬁcantly diﬀerent
levels between both groups. Apart from their structural function, GPLs
are involved in a wide array of cellular functions including protein and
glycoconjugate anchoring, host cell infection, and apoptosis-like pro-
cesses (Pulido et al., 2017). A second notable metabolic diﬀerence
concerned the urea cycle. In ISC1 versus CG we detected a higher
concentration of citrulline and a lower concentration of arginino-
succinate. In organisms with a complete urea cycle, argininosuccinate is
then further converted to arginine and fumarate by argininosuccinate
lyase (ASL), however, in Leishmania this enzyme is missing (Sardar
et al., 2016). This diﬀerence is of particular interest since both
argininosuccinate and arginine deprivation have been linked with re-
duced thiol content (Sardar et al., 2016; Mandal et al., 2016) and ASS
mutants have shown a lower virulence than WT parasites (Lakhal-
Naouar et al., 2012). Therefore, the importance of ASS should be fur-
ther analyzed. Finally, a metabolic change that also came forward in
our comparisons between ISC1 and CG strains was the nucleotide sal-
vage pathway. This pathway is essential, since Leishmania cannot syn-
thesize the purine ring de novo and is therefore dependent on salvaging
these from host purines (Boitz et al., 2012). Our results suggest that
ISC1 parasites might be better at salvaging nucleotides from their en-
vironment. Altogether, ISC1 and CG parasites appeared to show dif-
ferent levels of activity among diﬀerent metabolic pathways, all of them
susceptible to predict diﬀerences in virulence, which should be tested
by further work. Notably, our observations were made in stationary
phase axenic promastigotes, which contain a high degree of metacyclic,
infectious promastigotes (Jamdhade et al., 2015). This is of particular
interest, since virulence is of essential importance to this life stage.
However, it is certainly possible that more diﬀerences between ISC1
and CG might come forward when studying additional parasite life
stages in follow-up studies. Ultimately, the rapidly evolving metabo-
lomics technology will most likely allow metabolite quantiﬁcations of
low amounts of cells in vivo, or even single-cells in the future
(Madhubala et al., 2008).
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Fig. 4. The 40 diﬀerentially expressed glycerophospholipids (|Log2FC| > 1 & p < 0.05) between ISC1 and CG parasites.
B. Cuypers et al. Infection, Genetics and Evolution 62 (2018) 170–178
175
The parallel untargeted analysis of genome and metabolome of
diﬀerent L. donovani strains also allowed us to undertake a ﬁrst in-
tegration of both datasets. A quantitative approach was attempted by
directly correlating the pairwise GD-distance and metabolic distances
between strains. Although this correlation was found to be signiﬁcant,
they also demonstrate that the genomic distances only explain a limited
part of the variation observed at the metabolome level. This is not
unexpected, since regulation of gene expression in Trypanosomatids is
essentially post-transcriptional. Qualitative analysis of our results
showed a few correspondences between genomic and metabolic mar-
kers (Fig. 5). Correspondence could concern either an enzyme and the
speciﬁc metabolites of the reaction it catalyses, or this enzyme and
metabolites from the same pathway. The former is best illustrated by
the argininosuccinate synthase (ASS) and argininosuccinate, the gene
encoding ASS is located on the H-locus and had a 6.7 fold lower ex-
pression in ISC1 by the combined eﬀect of somy and local copy number
and argininosuccinate is 3.6 times less abundant in the metabolome of
ISC1. Two other examples of convergence between genomics and me-
tabolomics concern pathways: genes and metabolites pointing towards
a same altered pathway, even if they did not point towards the same
product. Firstly, the major changes revealed in the lipid metabolism by
metabolomics were mirrored by CNVs. We found 1.55 copies per hap-
loid genome more in ISC1 for diacyl glycerol acyltransferase, which is
part of the GPC biosynthesis pathway. Interestingly, we found pre-
dominantly higher GPC levels in ISC1. A CNV was also found in a fatty
acid elongase (1.65 copies per haploid genome more in ISC1), which is
an enzyme responsible for the extension of fatty acids that are later used
to build GPLs. Another CNV related to GPL building blocks was found in
the glycerol uptake protein. Finally, a CNV was found in 3-ketoacyl-CoA
thiolase, which is located in the glycosome and an enzyme of the β-
oxidation pathway (breakdown of fatty acids) (Jamdhade et al., 2015).
We also detected high impact SNPs in the ISC1 group for two enzymes
that are important for lipid signaling: a premature stop codon was in
phosphatidylinositol 3&4-kinase and a stop codon was removed from
CDP-diacylglycerol-inositol 3-phosphatidyl transferase. Secondly, the
diﬀerent activity of the salvage pathway revealed by metabolomics was
also mirrored by genomics. We found indeed that ISC1 parasites have
four copies more of the p1/s1 nuclease, which is part of the salvage
pathway and responsible for digesting the ssRNA and ssDNA to nu-
cleotides. This was accompanied by an increase of guanine, uracil,
thymine and AMP in ISC1. In summary, our data strongly suggest that
gene copy number variation may be an important adaptation strategy of
the parasite as shown by the gene dosage changes related to metabolic
pathways where metabolites were altered (Fig. 5). This implies corre-
sponding changes in protein levels, which is somewhat surprising as
transcript levels (driven by gene dosage) are generally assumed to
match poorly with protein levels (Madhubala et al., 2008). However,
these observations were made in context of diﬀerentiation, rather than
inter-strains comparisons as we have performed here. Our data suggest
that between strains, gene dosage levels might in fact drive protein
levels, as was also found in yeast, however, further work is required to
deﬁne the extent of agreement between variation of genome and pro-
teome.
The evolutionary history and origin of L. donovani ISC1 are still
unclear. In a previous work, genomic data allowed us to estimate the
origin of the CG around 1850, hereby ﬁtting with the dates mentioned
in the early reports of the ﬁrst epidemics of “Quinine-resistant malaria”
in the ISC, which later on appeared to be VL (Imamura et al., 2016).
However, when comparing the number of SNPs between ISC1 and CG
and the number of SNPs within CG (45,743 and 2418, respectively, as
previously published with a larger sample and an earlier version of the
reference genome (3)), we may conclude that divergence time between
ISC1 and CG is much earlier than 1850, probably several thousands of
years (or more). This suggests that ISC1 and CG represent two post-
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Key diﬀerences ISC1 vs CG shared between genome and metabolome
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CG ISC1
GPL biosynthec enzymes ↗
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Fig. 5. The 3 key diﬀerences between ISC1 and CG that are shared between genome and metabolome. 1. Argininosuccinate (ASS) has a lower genomic copy number
in ISC1 vs CG. More citrulline and less argininosuccinate were detected in ISC1, suggesting a corresponding downregulation of the ASS protein. Although the urea
cycle might be incomplete in Leishmania, links have been established with Trypanothione biosynthesis and virulence. 2. Several glycerophospholipid (or precursor)
biosynthetic enzymes had higher gene copy numbers in ISC1 which could be linked to increased GPL amounts (See also Fig. 4). 3. More copies of a p1/s1 nuclease
gene were found in ISC1, associated with higher concentrations of several salvage pathway metabolites. Genomic copy number information is underlined and in bold.
Pathway names are in italics. Arrows in grey represent potentially missing enzymes in the urea cycle of Leishmania. Blue= down in ISC1, Red=up in ISC1. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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bottleneck groups of a historically much more polymorphic population
endemic in the ISC, although we cannot exclude that one or both were
recently introduced from another, currently unsampled VL region. The
further fate of ISC1 in the Indian sub-continent remains to be de-
termined by molecular tracking. In the context of the current elimina-
tion program, it is possible that new and strong evolutionary bottle-
necks may emerge. Among the possible scenarios, the size of the CG
population could be strongly reduced, while emerging populations like
ISC1 could be favored and spread over the region. Such a scenario is
supported by (i) the presence of these variants in regions where the
elimination program could be less active, like in the highlands and (ii)
the functional diﬀerences predicted by the present work.
In summary, we have shown that the ISC1 population is very dif-
ferent in genotype and phenotype from the CG population that drove
most recent epidemic of VL in the ISC and that was aﬀected by drug
resistance. Genomic and metabolic approaches pointed out major
changes in pathways and molecules that are important for the inter-
action with the host/extracellular environment. Therefore, further work
should be performed to deeply characterize ISC1 parasites, especially at
functional level. A particular attention is also required to monitor the
fate of this emerging population in the ISC, especially in a post-elim-
ination context.
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